➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Moodys
Express Scripts
McKesson
Harvard Business School
Mallinckrodt

Last Updated: June 25, 2021

DrugPatentWatch Database Preview

RITUXAN Drug Profile


Email this page to a colleague

« Back to Dashboard

Recent Clinical Trials for RITUXAN

Identify potential brand extensions & biosimilar entrants

SponsorPhase
Incyte CorporationPhase 3
AbbViePhase 1
Oregon Health and Science UniversityPhase 1

See all RITUXAN clinical trials

Recent Litigation for RITUXAN

Identify key patents and potential future biosimilar entrants

District Court Litigation
Case NameDate
Ravgen, Inc. v. Progenity, Inc.2020-12-20
Ravgen, Inc. v. Myriad Genetics, Inc.2020-12-20
Ravgen, Inc. v. Illumina, Inc.2020-12-02

See all RITUXAN litigation

PTAB Litigation
PetitionerDate
Celltrion, Inc.2018-05-04
Apotex Inc.2018-02-23
Forty Seven, Inc.2018-01-08

See all RITUXAN litigation

Pharmacology for RITUXAN

Patent Text Search: US Patents for RITUXAN

These patents were identified by searching patent claims

Supplementary Protection Certificates for RITUXAN

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
132016000119245 Italy   Get Started Free PRODUCT NAME: IBRUTINIB O UN SUO SALE FARMACEUTICAMENTE ACCETTABILE PER IL TRATTAMENTO DI PAZIENTI ADULTI CON LEUCEMIA LINFOCITICA CRONICA (CLL) PRECEDENTEMENTE NON TRATTATA(IMBRUVICA); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/14/945, 20160530
LUC00044 Luxembourg   Get Started Free PRODUCT NAME: INOTUZUMAB OZOGAMICINE ET SES DERIVES PHARMACEUTIQUEMENT ACCEPTABLES (BESPONSA ); AUTHORISATION NUMBER AND DATE: EU/1/17/1200 20170703
18/2015 Austria   Get Started Free PRODUCT NAME: IBRUTINIB ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ; REGISTRATION NO/DATE: EU/1/14/945 20141021
212 50002-2015 Slovakia   Get Started Free PRODUCT NAME: POMALIDOMID; REGISTRATION NO/DATE: EU/1/13/850/001 - EU/1/13/850/004 20130808
1790062-2 Sweden   Get Started Free PRODUCT NAME: SARILUMAB; REG. NO/DATE: EU/1/17/1196 20170627
5/2015 Austria   Get Started Free PRODUCT NAME: POMALIDOMID UND SEINE PHARMAZEUTISCH AKZEPTABLEN SALZE, SOLVATE, HYDRATE ODER STEREOISOMERE; REGISTRATION NO/DATE: EU/1/13/850 20130805
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Johnson and Johnson
Baxter
Express Scripts
McKinsey
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.